162 related articles for article (PubMed ID: 28422118)
1. Nutrient regulation of β-cell function: what do islet cell/animal studies tell us?
Carlessi R; Keane KN; Mamotte C; Newsholme P
Eur J Clin Nutr; 2017 Jul; 71(7):890-895. PubMed ID: 28422118
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
3. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance].
Zeng CJ; Zhang L; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):658-63. PubMed ID: 21092544
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell behavior during the prediabetic stage. Part I. Beta-cell pathophysiology.
Homo-Delarche F
Diabetes Metab; 1997 Jun; 23(3):181-94. PubMed ID: 9233994
[TBL] [Abstract][Full Text] [Related]
5. Metabolic factors that affect beta-cell function and survival.
Purrello F; Rabuazzo AM
Diabetes Nutr Metab; 2000 Apr; 13(2):84-91. PubMed ID: 10898126
[TBL] [Abstract][Full Text] [Related]
6. Beta cell connectivity in pancreatic islets: a type 2 diabetes target?
Rutter GA; Hodson DJ
Cell Mol Life Sci; 2015 Feb; 72(3):453-467. PubMed ID: 25323131
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic steatosis in humans: cause or marker of lipotoxicity?
van Raalte DH; van der Zijl NJ; Diamant M
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):478-85. PubMed ID: 20489606
[TBL] [Abstract][Full Text] [Related]
8. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.
Movassat J; Saulnier C; Serradas P; Portha B
Diabetologia; 1997 Aug; 40(8):916-25. PubMed ID: 9267986
[TBL] [Abstract][Full Text] [Related]
9. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.
Li J; Chen L; Zhang Y; Zhang WJ; Xu W; Qin Y; Xu J; Zou D
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1030-8. PubMed ID: 23985305
[TBL] [Abstract][Full Text] [Related]
10. Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity.
McKillop AM; Abdel-Wahab YH; Mooney MH; O'Harte FP; Flatt PR
Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S61-9; discussion 3S108-12. PubMed ID: 12688635
[TBL] [Abstract][Full Text] [Related]
11. [Transmitted beta-cell dysfunction as a cause for type 2-diabetes].
Portha B
Med Sci (Paris); 2003; 19(8-9):847-53. PubMed ID: 14593616
[TBL] [Abstract][Full Text] [Related]
12. Toward an integrated phenotype in pre-NIDDM.
Bergman RN; Watanabe R; Rebrin K; Ader M; Steil G
Diabet Med; 1996 Sep; 13(9 Suppl 6):S67-77. PubMed ID: 8894486
[TBL] [Abstract][Full Text] [Related]
13. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet.
Falcão VT; Maschio DA; de Fontes CC; Oliveira RB; Santos-Silva JC; Almeida AC; Vanzela EC; Cartaxo MT; Carvalho CP; Collares-Buzato CB
Histochem Cell Biol; 2016 Jul; 146(1):13-31. PubMed ID: 27020567
[TBL] [Abstract][Full Text] [Related]
14. Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction.
Halter JB; Beard JC; Porte D
Am J Physiol; 1984 Jul; 247(1 Pt 1):E47-52. PubMed ID: 6377920
[TBL] [Abstract][Full Text] [Related]
15. Five stages of progressive β-cell dysfunction in the laboratory Nile rat model of type 2 diabetes.
Yang K; Gotzmann J; Kuny S; Huang H; Sauvé Y; Chan CB
J Endocrinol; 2016 Jun; 229(3):343-56. PubMed ID: 27068697
[TBL] [Abstract][Full Text] [Related]
16. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
[TBL] [Abstract][Full Text] [Related]
17. Role of islet amyloid in type 2 diabetes mellitus.
Höppener JW; Lips CJ
Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide in the islets of Langerhans: friend or foe?
Gebre-Medhin S; Olofsson C; Mulder H
Diabetologia; 2000 Jun; 43(6):687-95. PubMed ID: 10907112
[TBL] [Abstract][Full Text] [Related]
19. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
[TBL] [Abstract][Full Text] [Related]
20. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
